Ignite Creation Date:
2024-05-06 @ 4:24 PM
Last Modification Date:
2024-10-26 @ 2:09 PM
Study NCT ID:
NCT04976322
Status:
ENROLLING_BY_INVITATION
Last Update Posted:
2024-07-12
First Post:
2021-07-14
Brief Title:
A Study to Evaluate the Safety and Tolerability of Dapirolizumab Pegol in Study Participants With Systemic Lupus Erythematosus
Sponsor:
UCB Biopharma SRL
Organization:
UCB Pharma
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-07-27
Start Date Type:
ACTUAL
Primary Completion Date:
2029-04-10
Primary Completion Date Type:
ESTIMATED
Completion Date:
2029-04-10
Completion Date Type:
ESTIMATED
First Submit Date:
2021-07-14
First Submit QC Date:
July 14 2021
Study First Post Date:
2021-07-26
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-17
Last Update Post Date:
2024-07-12
Last Update Post Date Type:
ACTUAL